• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 432609 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414675714 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414675714 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Traders Get Bullish on Shares of Cleveland Biolabs, Shares Up 6.2% (CBLI)

Published on Wed, 01/30/2013 - 13:23
By Robert Cotter

Cleveland Biolabs (NASDAQ:CBLI) is one of today's best performing low-priced stocks, up 6.2% to $1.62 on 1.1x average daily volume. Thus far today, Cleveland Biolabs has traded 295,000 shares, vs. average volume of 266,000 shares per day. The stock has outperformed the Dow (6.6% to the Dow's 0.1%) and outperformed the S&P 500 (6.6% to the S&P's -0.0%) during today's trading.

Cleveland Biolabs, Inc. develops pharmaceuticals. The Company develops drugs to protect humans from exposure to radiation.

Cleveland Biolabs share prices have moved between a 52-week high of $4.06 and a 52-week low of $1.15 and are now trading 41% above that low price at $1.62 per share. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.9%.

There is potential upside of 85.2% for shares of Cleveland Biolabs based on a current price of $1.62 and an average consensus analyst price target of $3.00. Cleveland Biolabs shares should encounter resistance at the 200-day moving average (MA) of $1.68 and support at the 50-day MA of $1.43.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Possible Bearish Inside Day Candle Patte...

Analyzing the price chart for HEICO (NYSE:HEI) has revealed a potential bearish inside ...

Possible Bearish Inside Day Candle Patte...

Analysts have spotted a possible bearish inside day candle pattern in American Vanguard ...

Analysis of Relative Performance in the ...

Here are 5 stocks in the Trucking industry ranked by performance. We compiled the trad ...

Bottom 5 Companies in the Systems Softwa...

Here are 5 stocks in the Systems Software industry ranked by performance. We compiled ...

Analysis of Relative Performance in the ...

Analysis was conducted on the Steel industry to measure relative performance to find st ...

Shares of Office Depot Underperformed it...

Analysis was conducted on the Specialty Stores industry to measure relative performance ...

Analysis of Relative Performance in the ...

Below are five companies in the Specialty Chemicals industry that underperformed yester ...

Weyerhaeuser has Relatively Underperform...

Here are 5 stocks in the Specialized REITs industry ranked by performance. We compiled ...